Guy Loic Nguefang

Name matching only

Publications

Citations

h-index

Computed over the works the graph holds, so it is a floor rather than a career figure.

i10-index

Publications

10 works in the graph, newest first.

FibroAgent: An Agentic AI Tool for Liver Fibrosis Screening and Clinical Decision Support in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
2026CureusJournalOpen access1 citations10.7759/cureus.106372
Increased Risk of Alzheimer Disease–Associated Mortality in Nonobese vs Obese Metabolic Dysfunction–Associated Steatotic Liver Disease: A 30-Year National Cohort Study
2026Gastro Hep AdvancesJournalOpen access1 citations10.1016/j.gastha.2026.101030
Outcomes of GLP-1 receptor agonist therapy in adults with sickle cell disease and type 2 diabetes: a real-world cohort analysis
2026Orphanet Journal of Rare DiseasesJournalOpen accessFirst author1 citations10.1186/s13023-026-04322-5
Additional file 1 of Outcomes of GLP-1 receptor agonist therapy in adults with sickle cell disease and type 2 diabetes: a real-world cohort analysis
2026FigshareJournalOpen accessFirst author0 citations10.6084/m9.figshare.31931931.v1
Additional file 1 of Outcomes of GLP-1 receptor agonist therapy in adults with sickle cell disease and type 2 diabetes: a real-world cohort analysis
2026FigshareJournalOpen accessFirst author0 citations10.6084/m9.figshare.31931931
Effect of coded steatotic liver disease on outcomes of percutaneous coronary intervention in non-diabetic adults: insights from a multicenter real-world cohort
2026BMC Cardiovascular DisordersJournalOpen access0 citations10.1186/s12872-026-06017-y
Optimal Timing of GLP-1 Receptor Agonist Initiation in Patients with Obesity Eligible for Metabolic Bariatric Surgery
2026Obesity SurgeryJournalFirst authorCorresponding0 citations10.1007/s11695-026-08864-2
Additional file 1 of Effect of coded steatotic liver disease on outcomes of percutaneous coronary intervention in non-diabetic adults: insights from a multicenter real-world cohort
2026FigshareJournalOpen access0 citations10.6084/m9.figshare.33107772.v1
Additional file 1 of Effect of coded steatotic liver disease on outcomes of percutaneous coronary intervention in non-diabetic adults: insights from a multicenter real-world cohort
2026FigshareJournalOpen access0 citations10.6084/m9.figshare.33107772
Volatomic profiling of blood identifies environmental chemicals associated with metabolic dysfunction–associated steatotic liver disease in lean US adults
2026Baylor University Medical Center ProceedingsJournal0 citations10.1080/08998280.2026.2713923